• Accueil >
  • Publications >
  • Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study

1 août 2021Clinical Genitourinary Cancer

DOI : 10.1016/j.clgc.2021.02.005

Auteurs

Stéphane Culine, Aude Fléchon, Gwenaelle Gravis, Guilhem Roubaud, Yohann Loriot, Florence Joly, Philippe Barthélémy, Elias Assaf, Hakim Mahammedi, Philippe Beuzeboc, Nadine Houédé, Frédéric Rolland, Aline Guillot, Marine Gross-Goupil, Jean-Philippe Spano, Sophie Tartas, Mathilde Deblock, Christine Chevreau, Camille Serrate, Hélène Manduzio, Muriel Habibian, Simon Thézénas, Yves Allory